mRNA Vaccines & Therapeutics-Europe Market Status and Trend Report 2015-2026
Report Summary
mRNA Vaccines & Therapeutics-Europe Market Status and Trend Report 2015-2026 offers a comprehensive analysis on mRNA Vaccines & Therapeutics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of mRNA Vaccines & Therapeutics 2015-2019, and development forecast 2020-2026
Main market players of mRNA Vaccines & Therapeutics in Europe, with company and product introduction, position in the mRNA Vaccines & Therapeutics market
Market status and development trend of mRNA Vaccines & Therapeutics by types and applications
Cost and profit status of mRNA Vaccines & Therapeutics, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium mRNA Vaccines & Therapeutics market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the mRNA Vaccines & Therapeutics industry.
The report segments the Europe mRNA Vaccines & Therapeutics market as:
Europe mRNA Vaccines & Therapeutics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe mRNA Vaccines & Therapeutics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Infectious Disease Vaccines
Cancer Vaccines
Europe mRNA Vaccines & Therapeutics Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Infectious Disease
Cancer
Europe mRNA Vaccines & Therapeutics Market: Players Segment Analysis (Company and Product introduction, mRNA Vaccines & Therapeutics Sales Volume, Revenue, Price and Gross Margin):
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
mRNA Vaccines & Therapeutics-Europe Market Status and Trend Report 2015-2026 offers a comprehensive analysis on mRNA Vaccines & Therapeutics industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of mRNA Vaccines & Therapeutics 2015-2019, and development forecast 2020-2026
Main market players of mRNA Vaccines & Therapeutics in Europe, with company and product introduction, position in the mRNA Vaccines & Therapeutics market
Market status and development trend of mRNA Vaccines & Therapeutics by types and applications
Cost and profit status of mRNA Vaccines & Therapeutics, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium mRNA Vaccines & Therapeutics market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the mRNA Vaccines & Therapeutics industry.
The report segments the Europe mRNA Vaccines & Therapeutics market as:
Europe mRNA Vaccines & Therapeutics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe mRNA Vaccines & Therapeutics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Infectious Disease Vaccines
Cancer Vaccines
Europe mRNA Vaccines & Therapeutics Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Infectious Disease
Cancer
Europe mRNA Vaccines & Therapeutics Market: Players Segment Analysis (Company and Product introduction, mRNA Vaccines & Therapeutics Sales Volume, Revenue, Price and Gross Margin):
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MRNA VACCINES & THERAPEUTICS
1.1 Definition of mRNA Vaccines & Therapeutics in This Report
1.2 Commercial Types of mRNA Vaccines & Therapeutics
1.2.1 Infectious Disease Vaccines
1.2.2 Cancer Vaccines
1.3 Downstream Application of mRNA Vaccines & Therapeutics
1.3.1 Infectious Disease
1.3.2 Cancer
1.4 Development History of mRNA Vaccines & Therapeutics
1.5 Market Status and Trend of mRNA Vaccines & Therapeutics 2015-2026
1.5.1 Europe mRNA Vaccines & Therapeutics Market Status and Trend 2015-2026
1.5.2 Regional mRNA Vaccines & Therapeutics Market Status and Trend 2015-2026
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of mRNA Vaccines & Therapeutics in Europe 2015-2019
2.2 Consumption Market of mRNA Vaccines & Therapeutics in Europe by Regions
2.2.1 Consumption Volume of mRNA Vaccines & Therapeutics in Europe by Regions
2.2.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Regions
2.3 Market Analysis of mRNA Vaccines & Therapeutics in Europe by Regions
2.3.1 Market Analysis of mRNA Vaccines & Therapeutics in Germany 2015-2019
2.3.2 Market Analysis of mRNA Vaccines & Therapeutics in United Kingdom 2015-2019
2.3.3 Market Analysis of mRNA Vaccines & Therapeutics in France 2015-2019
2.3.4 Market Analysis of mRNA Vaccines & Therapeutics in Italy 2015-2019
2.3.5 Market Analysis of mRNA Vaccines & Therapeutics in Spain 2015-2019
2.3.6 Market Analysis of mRNA Vaccines & Therapeutics in Benelux 2015-2019
2.3.7 Market Analysis of mRNA Vaccines & Therapeutics in Russia 2015-2019
2.4 Market Development Forecast of mRNA Vaccines & Therapeutics in Europe 2020-2026
2.4.1 Market Development Forecast of mRNA Vaccines & Therapeutics in Europe 2020-2026
2.4.2 Market Development Forecast of mRNA Vaccines & Therapeutics by Regions 2020-2026
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of mRNA Vaccines & Therapeutics in Europe by Types
3.1.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of mRNA Vaccines & Therapeutics in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of mRNA Vaccines & Therapeutics in Europe by Downstream Industry
4.2 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Major Countries
4.2.1 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Germany
4.2.2 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in United Kingdom
4.2.3 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in France
4.2.4 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Italy
4.2.5 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Spain
4.2.6 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Benelux
4.2.7 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Russia
4.3 Market Forecast of mRNA Vaccines & Therapeutics in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MRNA VACCINES & THERAPEUTICS
5.1 Europe Economy Situation and Trend Overview
5.2 mRNA Vaccines & Therapeutics Downstream Industry Situation and Trend Overview
CHAPTER 6 MRNA VACCINES & THERAPEUTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of mRNA Vaccines & Therapeutics in Europe by Major Players
6.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Major Players
6.3 Basic Information of mRNA Vaccines & Therapeutics by Major Players
6.3.1 Headquarters Location and Established Time of mRNA Vaccines & Therapeutics Major Players
6.3.2 Employees and Revenue Level of mRNA Vaccines & Therapeutics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MRNA VACCINES & THERAPEUTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Moderna Therapeutics
7.1.1 Company profile
7.1.2 Representative mRNA Vaccines & Therapeutics Product
7.1.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Moderna Therapeutics
7.2 eTheRNA
7.2.1 Company profile
7.2.2 Representative mRNA Vaccines & Therapeutics Product
7.2.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of eTheRNA
7.3 BioNTech
7.3.1 Company profile
7.3.2 Representative mRNA Vaccines & Therapeutics Product
7.3.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of BioNTech
7.4 CureVac
7.4.1 Company profile
7.4.2 Representative mRNA Vaccines & Therapeutics Product
7.4.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of CureVac
7.5 In-Cell-Art
7.5.1 Company profile
7.5.2 Representative mRNA Vaccines & Therapeutics Product
7.5.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of In-Cell-Art
7.6 Translate Bio
7.6.1 Company profile
7.6.2 Representative mRNA Vaccines & Therapeutics Product
7.6.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Translate Bio
7.7 Tiba Biotechnology
7.7.1 Company profile
7.7.2 Representative mRNA Vaccines & Therapeutics Product
7.7.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Tiba Biotechnology
7.8 Argos Therapeutics
7.8.1 Company profile
7.8.2 Representative mRNA Vaccines & Therapeutics Product
7.8.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Argos Therapeutics
7.9 Sangamo Therapeutics
7.9.1 Company profile
7.9.2 Representative mRNA Vaccines & Therapeutics Product
7.9.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Sangamo Therapeutics
7.10 Ethris
7.10.1 Company profile
7.10.2 Representative mRNA Vaccines & Therapeutics Product
7.10.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Ethris
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MRNA VACCINES & THERAPEUTICS
8.1 Industry Chain of mRNA Vaccines & Therapeutics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MRNA VACCINES & THERAPEUTICS
9.1 Cost Structure Analysis of mRNA Vaccines & Therapeutics
9.2 Raw Materials Cost Analysis of mRNA Vaccines & Therapeutics
9.3 Labor Cost Analysis of mRNA Vaccines & Therapeutics
9.4 Manufacturing Expenses Analysis of mRNA Vaccines & Therapeutics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MRNA VACCINES & THERAPEUTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of mRNA Vaccines & Therapeutics in This Report
1.2 Commercial Types of mRNA Vaccines & Therapeutics
1.2.1 Infectious Disease Vaccines
1.2.2 Cancer Vaccines
1.3 Downstream Application of mRNA Vaccines & Therapeutics
1.3.1 Infectious Disease
1.3.2 Cancer
1.4 Development History of mRNA Vaccines & Therapeutics
1.5 Market Status and Trend of mRNA Vaccines & Therapeutics 2015-2026
1.5.1 Europe mRNA Vaccines & Therapeutics Market Status and Trend 2015-2026
1.5.2 Regional mRNA Vaccines & Therapeutics Market Status and Trend 2015-2026
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of mRNA Vaccines & Therapeutics in Europe 2015-2019
2.2 Consumption Market of mRNA Vaccines & Therapeutics in Europe by Regions
2.2.1 Consumption Volume of mRNA Vaccines & Therapeutics in Europe by Regions
2.2.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Regions
2.3 Market Analysis of mRNA Vaccines & Therapeutics in Europe by Regions
2.3.1 Market Analysis of mRNA Vaccines & Therapeutics in Germany 2015-2019
2.3.2 Market Analysis of mRNA Vaccines & Therapeutics in United Kingdom 2015-2019
2.3.3 Market Analysis of mRNA Vaccines & Therapeutics in France 2015-2019
2.3.4 Market Analysis of mRNA Vaccines & Therapeutics in Italy 2015-2019
2.3.5 Market Analysis of mRNA Vaccines & Therapeutics in Spain 2015-2019
2.3.6 Market Analysis of mRNA Vaccines & Therapeutics in Benelux 2015-2019
2.3.7 Market Analysis of mRNA Vaccines & Therapeutics in Russia 2015-2019
2.4 Market Development Forecast of mRNA Vaccines & Therapeutics in Europe 2020-2026
2.4.1 Market Development Forecast of mRNA Vaccines & Therapeutics in Europe 2020-2026
2.4.2 Market Development Forecast of mRNA Vaccines & Therapeutics by Regions 2020-2026
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of mRNA Vaccines & Therapeutics in Europe by Types
3.1.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of mRNA Vaccines & Therapeutics in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of mRNA Vaccines & Therapeutics in Europe by Downstream Industry
4.2 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Major Countries
4.2.1 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Germany
4.2.2 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in United Kingdom
4.2.3 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in France
4.2.4 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Italy
4.2.5 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Spain
4.2.6 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Benelux
4.2.7 Demand Volume of mRNA Vaccines & Therapeutics by Downstream Industry in Russia
4.3 Market Forecast of mRNA Vaccines & Therapeutics in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MRNA VACCINES & THERAPEUTICS
5.1 Europe Economy Situation and Trend Overview
5.2 mRNA Vaccines & Therapeutics Downstream Industry Situation and Trend Overview
CHAPTER 6 MRNA VACCINES & THERAPEUTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of mRNA Vaccines & Therapeutics in Europe by Major Players
6.2 Revenue of mRNA Vaccines & Therapeutics in Europe by Major Players
6.3 Basic Information of mRNA Vaccines & Therapeutics by Major Players
6.3.1 Headquarters Location and Established Time of mRNA Vaccines & Therapeutics Major Players
6.3.2 Employees and Revenue Level of mRNA Vaccines & Therapeutics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MRNA VACCINES & THERAPEUTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Moderna Therapeutics
7.1.1 Company profile
7.1.2 Representative mRNA Vaccines & Therapeutics Product
7.1.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Moderna Therapeutics
7.2 eTheRNA
7.2.1 Company profile
7.2.2 Representative mRNA Vaccines & Therapeutics Product
7.2.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of eTheRNA
7.3 BioNTech
7.3.1 Company profile
7.3.2 Representative mRNA Vaccines & Therapeutics Product
7.3.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of BioNTech
7.4 CureVac
7.4.1 Company profile
7.4.2 Representative mRNA Vaccines & Therapeutics Product
7.4.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of CureVac
7.5 In-Cell-Art
7.5.1 Company profile
7.5.2 Representative mRNA Vaccines & Therapeutics Product
7.5.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of In-Cell-Art
7.6 Translate Bio
7.6.1 Company profile
7.6.2 Representative mRNA Vaccines & Therapeutics Product
7.6.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Translate Bio
7.7 Tiba Biotechnology
7.7.1 Company profile
7.7.2 Representative mRNA Vaccines & Therapeutics Product
7.7.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Tiba Biotechnology
7.8 Argos Therapeutics
7.8.1 Company profile
7.8.2 Representative mRNA Vaccines & Therapeutics Product
7.8.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Argos Therapeutics
7.9 Sangamo Therapeutics
7.9.1 Company profile
7.9.2 Representative mRNA Vaccines & Therapeutics Product
7.9.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Sangamo Therapeutics
7.10 Ethris
7.10.1 Company profile
7.10.2 Representative mRNA Vaccines & Therapeutics Product
7.10.3 mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin of Ethris
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MRNA VACCINES & THERAPEUTICS
8.1 Industry Chain of mRNA Vaccines & Therapeutics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MRNA VACCINES & THERAPEUTICS
9.1 Cost Structure Analysis of mRNA Vaccines & Therapeutics
9.2 Raw Materials Cost Analysis of mRNA Vaccines & Therapeutics
9.3 Labor Cost Analysis of mRNA Vaccines & Therapeutics
9.4 Manufacturing Expenses Analysis of mRNA Vaccines & Therapeutics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MRNA VACCINES & THERAPEUTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
